Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area Sort descending
  • Date Posted
Job Title Site Location Division Business Functional Area Sort descending Date Posted
Lehre Labortechnik Schaftenau Austria Operations Innovative Medicines Others Sep 11, 2024
Lehrling Mechatronik Schaftenau Austria Operations Innovative Medicines Others Sep 11, 2024
Lehrling Chemieverfahrenstechnik Schaftenau Austria Operations Innovative Medicines Others Sep 12, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Switzerland Legal Corporate Others Sep 26, 2024
Legal Trainee / Rechtsreferendar (m/f/d) in der Rechtsanwaltsstation oder im Pflichtwahlpraktikum Munich (Novartis Business Services GmbH) Germany Legal CTS Others Oct 04, 2024
Duales Studium (Bachelor) BWL Industrie Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany People & Organization Innovative Medicines Others Oct 10, 2024
Duales Studium (Bachelor) BWL Gesundheitsmanagement Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany People & Organization Innovative Medicines Others Oct 10, 2024
QA Compliance Postgraduate Stein Aargau Switzerland Operations Innovative Medicines Others Oct 14, 2024
Legal Trainee – Research & Development and Innovative Medicines Basel (City) Switzerland Legal Innovative Medicines Others Oct 22, 2024
Supply Chain Graduate Program Associate - UAE National Dubai Utd.Arab Emir. Operations Innovative Medicines Others Oct 14, 2024
Legal Trainee - Novartis Operations Basel (City) Switzerland Operations CTS Others Oct 15, 2024
Next Generation Scientist 2025 Basel (City) Switzerland Biomedical Research Innovative Medicines Others Oct 01, 2024
Legal Trainee - Legal Procurement, Data/Digital & IT Basel (City) Switzerland Legal CTS Others Oct 10, 2024
Digital Project Intern Rotkreuz (Office-Based) Switzerland International Innovative Medicines Others Oct 15, 2024
Chef de Projet Omnicanal – Apprenti H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Jul 04, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant MARKET ACCES Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) France Finance Innovative Medicines Others May 17, 2024
ALTERNANT Expert en développement des compétences Paris Headquarter (Novartis Pharma S.A.S.) France Innovative Medicines Others May 21, 2024
Alternant INGENIEUR DATA Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 23, 2024
Alternant CHEF DE PROJET (Maladie de Verneuil/Urticaire Chronique) Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others May 28, 2024
APPRENTI(E) COORDINATEUR FORMATION (H/F) Huningue France Operations Innovative Medicines Others May 31, 2024
APPRENTI(E) ANIMATEUR SSE (H/F) Huningue France Operations Innovative Medicines Others Jun 10, 2024
HR Data Analyst & Communication H/F en Alternance Paris Headquarter (Novartis Pharma S.A.S.) France People & Organization Innovative Medicines Others Jul 04, 2024
Recent Bachelor or Master Graduate Basel (City) Switzerland Biomedical Research Pharma Research Others Oct 22, 2024
Analyst Stratégique H/F) en Stage Rueil-Malmaison France International Innovative Medicines Others Aug 19, 2024
Embrace Advisor Verona Field Force (Italy) Italy International Innovative Medicines Others Oct 16, 2024
IT Strategic Business Partner US&I (Salesforce) Barcelona Gran Vía Spain Operations CTS Technology Transformation Oct 01, 2024
Associate Director for Information Security and Compliance, M&A Team Prague Czech Republic Operations CTS Technology Transformation Aug 20, 2024
Assoc. Dir. DDIT Dev. Business Analyst, Global Clinical Operations Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 21, 2024
Associate Director, Business Analyst, DDIT Dev., Technical Research & Development (TRD) Barcelona Gran Vía Spain Operations CTS Technology Transformation Aug 22, 2024
Sr Specialist DDIT IM JP & APMA Soln Int Selangor Malaysia Operations CTS Technology Transformation Aug 22, 2024
Associate Director, Veeva CRM Architect Barcelona Gran Vía Spain Operations CTS Technology Transformation Sep 03, 2024
Associate Director Enterprise Architect -IAM Barcelona Gran Vía Spain Operations CTS Technology Transformation Sep 04, 2024
Associate Director OPX Planning Prague Czech Republic Operations CTS Technology Transformation Sep 06, 2024
Business process expert - Life Sciences(Regulatory, CSR, PV) Hyderabad (Office) India Operations CTS Technology Transformation Sep 09, 2024
Associate Director – Conferencing Platform Services INSURGENTES Mexico Operations CTS Technology Transformation Sep 09, 2024
Junior Engineer - Conferencing (AR / VR platforms) Prague Czech Republic Operations CTS Technology Transformation Jul 22, 2024
Associate Director - Cloud Security Architect Prague Czech Republic Operations CTS Technology Transformation Jul 23, 2024
LDC IT Planning Manager Prague Czech Republic Operations CTS Technology Transformation Sep 03, 2024
Project Manager Selangor Malaysia Operations CTS Technology Transformation Sep 03, 2024
Višji specialist proizvodno informacijskih sistemov / Senior Specialist IT MES Ljubljana Slovenia Operations CTS Technology Transformation Sep 03, 2024
Senior Specialist IT (Service Operations Expert) Prague Czech Republic Operations CTS Technology Transformation Sep 03, 2024
Sr. Spec. DDIT IES NetSec Engg Hyderabad (Office) India Operations CTS Technology Transformation Apr 16, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC Ent Arch Digit Sec Hyderabad (Office) India Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC VulnSvcs role Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Sr. Bus. Analyst DDIT US&I CPM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) India Operations CTS Technology Transformation Apr 17, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only